TIGECYCLINE ACCORD, TIGECYCLINE INTAS (Accord Healthcare Pty Ltd)
Product name
TIGECYCLINE ACCORD, TIGECYCLINE INTAS
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
142 (255 working days)
Active ingredients
tigecycline
Registration type
New generic medicine
Indication
TIGECYCLINE ACCORD, TIGECYCLINE INTAS (powder for injection) is indicated for the treatment of the following infections in adults:
- Complicated skin and skin structure infections, including those with methicillin-resistant Staphylococcus aureus (MRSA), where there is suspected or proven resistance to, intolerance of, or there are co-morbidities preventing the use of, other available agents.
- Complicated intra-abdominal infections, where there is suspected or proven resistance to, intolerance of, or there are co-morbidities preventing the use of, other available agents.